<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" > <channel><title>Comments on: P4P for drugs</title> <atom:link href="http://www.kevinmd.com/blog/2007/07/p4p-for-drugs.html/feed" rel="self" type="application/rss+xml" /><link>http://www.kevinmd.com/blog/2007/07/p4p-for-drugs.html</link> <description></description> <lastBuildDate>Tue, 14 Feb 2012 17:14:00 +0000</lastBuildDate> <sy:updatePeriod>hourly</sy:updatePeriod> <sy:updateFrequency>1</sy:updateFrequency> <xhtml:meta xmlns:xhtml="http://www.w3.org/1999/xhtml" name="robots" content="noindex" /> <item><title>By: Maurice Bernstein, M.D.</title><link>http://www.kevinmd.com/blog/2007/07/p4p-for-drugs.html#comment-77703</link> <dc:creator>Maurice Bernstein, M.D.</dc:creator> <pubDate>Sun, 15 Jul 2007 01:39:00 +0000</pubDate> <guid isPermaLink="false">http://clients.emmense.com/kevinmd/2007/07/p4p-for-drugs.html#comment-77703</guid> <description>By coincidence, I happened to post on my &lt;a HREF=&quot;&quot; REL=&quot;nofollow&quot; HTTP://BIOETHICSDISCUSSION.BLOGSPOT.COM&gt;Bioethics Discussion blog&lt;/a&gt; the broader topic of pay for performance regarding physicians and hospitals but also included the pharmaceutical aspect as written up in the New York Times article. The issue of what degree of shrinkage of a tumor should be called effective drug treatment in a patient and require payment for the drug is one thing. The issue of how to establish realistic benchmarks for physicians and hospitals with patients with complex medical conditions or intentional avoidance of those complex cases by healthcare providers is another matter. &lt;br/&gt;&lt;br/&gt;Kevin, your visitors may be interested in reading the current July 12, 2007 issue of the NEJM p.111 for the Perspective article &quot;Is Zero the Ideal Death Rate?&quot; which deals with benchmarks and report cards for evaluation of physician and hospital performance.&lt;br/&gt;..Maurice.</description> <content:encoded><![CDATA[<p>By coincidence, I happened to post on my <a HREF="" REL="nofollow" HTTP://BIOETHICSDISCUSSION.BLOGSPOT.COM>Bioethics Discussion blog</a> the broader topic of pay for performance regarding physicians and hospitals but also included the pharmaceutical aspect as written up in the New York Times article. The issue of what degree of shrinkage of a tumor should be called effective drug treatment in a patient and require payment for the drug is one thing. The issue of how to establish realistic benchmarks for physicians and hospitals with patients with complex medical conditions or intentional avoidance of those complex cases by healthcare providers is another matter.</p><p>Kevin, your visitors may be interested in reading the current July 12, 2007 issue of the NEJM p.111 for the Perspective article &#8220;Is Zero the Ideal Death Rate?&#8221; which deals with benchmarks and report cards for evaluation of physician and hospital performance.<br />..Maurice.</p> ]]></content:encoded> </item> </channel> </rss>
<!-- Performance optimized by W3 Total Cache. Learn more: http://www.w3-edge.com/wordpress-plugins/

Minified using apc
Page Caching using disk: enhanced
Database Caching 2/6 queries in 0.003 seconds using memcached
Object Caching 341/345 objects using apc
Content Delivery Network via cdn.kevinmd.com

Served from: www.kevinmd.com @ 2012-02-14 12:18:15 -->
